Prostaglandin D2 Receptor 2 Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Prostaglandin D2 Receptor 2 Market size is expected to grow at an annual average of 6% during 2022-2028. Prostaglandin D2 receptor 2 (a chemoattractant receptor homologous molecule expressed on Th2 cells or G protein-coupled receptor 44 or GPR44 or CD294 or PTGDR2) – The prostaglandin D2 (PGD2) receptor is a G protein-coupled receptor that binds to and activates D2. It mediates the inflammatory chemotaxis of eosinophils, basophils, and Th2 lymphocytes produced during allergic inflammation.

The following segmentation are covered in this report:

By Application

• Atopic Dermatitis
• Allergic Asthma
• Chronic Obstructive Pulmonary Disease
• Others

By Type

• OC-2417
• MK-1029
• BBI-5000
• ADC-7405
• Others

Company Profile

• Allergan Plc
• Brickell Biotech Inc
• Ligand Pharmaceuticals Inc
• Merck & Co Inc
• Novartis AG
• Oxagen Limited
• Panmira Pharmaceuticals, LLC
• Pulmagen Therapeutics LLP
• Taisho Pharmaceutical Holdings Co Ltd

Scope of the report

The research study analyses the Prostaglandin D2 Receptor 2 Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Prostaglandin D2 Receptor 2 Market Report

• What was the Prostaglandin D2 Receptor 2 Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Prostaglandin D2 Receptor 2 Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.